METABOLOMIC DATA OF EGFR-TKI-SENSITIVE CELLS VS. EGFR-TKI-RESISTANCE CELLS
Published: 12 July 2021| Version 1 | DOI: 10.17632/m9d29fhmc3.1
Contributors:
, , , Description
Epider growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) acquired-resistance remains unknown. We determined a metabolomics profiling comparing EGFR-TKI-resistant cells to EGFR-TKI-sensitive cells using UPLC-QTOF-MS.
Files
Categories
Oncology, Metabolomics